FDA Approves PET Imaging Agent for Brain Cancer Based on UCSF Data
September 14, 2026
September 14, 2026
SAN FRANCISCO, California, Sept. 14 -- The University of California San Francisco campus issued the following news release:
* * *
FDA Approves PET Imaging Agent for Brain Cancer Based on UCSF Data
UC San Francisco study data was instrumental in today's approval by the Food and Drug Administration (FDA) of a PET imaging agent that helps physicians evaluate gliomas, a form of brain cancer.
The approval of floretyrosine F 18 (18F-FET) was sup . . .
* * *
FDA Approves PET Imaging Agent for Brain Cancer Based on UCSF Data
UC San Francisco study data was instrumental in today's approval by the Food and Drug Administration (FDA) of a PET imaging agent that helps physicians evaluate gliomas, a form of brain cancer.
The approval of floretyrosine F 18 (18F-FET) was sup . . .